MBX Biosciences, Inc. Common Stock
MBX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21,618 | -$19,411 | -$23,880 | -$15,586 |
| Dep. & Amort. | $50 | -$979 | $77 | $58 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,245 | $1,937 | $1,839 | $1,488 |
| Change in WC | $531 | $918 | $600 | -$627 |
| Other Non-Cash | -$2,744 | $101 | -$1,314 | -$1,370 |
| Operating Cash Flow | -$21,536 | -$17,434 | -$22,678 | -$16,037 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$399 | -$707 | -$30 | -$92 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$47,429 | -$58,894 | -$87,503 |
| Inv. Sales/Matur. | $0 | $73,122 | $57,150 | $20,250 |
| Other Inv. Act. | $17,455 | $1,000 | $5,000 | $0 |
| Investing Cash Flow | $17,056 | $25,986 | $3,226 | -$67,345 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $1,326 | $4 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $187,824 | $0 | $0 | -$132 |
| Financing Cash Flow | $187,824 | $1,326 | $4 | -$132 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $183,344 | $9,878 | -$19,448 | -$83,514 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $39,781 | $29,903 | $49,351 | $132,865 |
| End Cash | $223,125 | $39,781 | $29,903 | $49,351 |
| Free Cash Flow | -$21,935 | -$18,141 | -$22,708 | -$16,129 |